Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
Classifica tra le azioni
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Prezzo delle azioni
$6.17
Capitalizzazione di mercato
$3.52B
Variazione (1 giorno)
-0.05%
Variazione (1 anno)
-1.86%
Paese
CN
Scambia Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Categoria
Healthcare
Utile per Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited dal 2001 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2025 | $355.53M | 0.63% |
| 2024 | $353.30M | 128.32% |
| 2023 | $154.74M | 8.90% |
| 2022 | $142.10M | 3.48% |
| 2021 | $137.32M | 16.80% |
| 2020 | $117.57M | 10.16% |
| 2019 | $106.72M | 14.59% |
| 2018 | $93.13M | 14.11% |
| 2017 | $81.61M | 21.49% |
| 2016 | $67.18M | -18.79% |
| 2015 | $82.72M | 18.91% |
| 2014 | $69.56M | 1.17% |
| 2013 | $68.76M | -17.14% |
| 2012 | $82.98M | 85.74% |
| 2011 | $44.67M | -16.41% |
| 2010 | $53.45M | 42.73% |
| 2009 | $37.45M | 56.81% |
| 2008 | $23.88M | -711.08% |
| 2007 | $-3.91M | -92.20% |
| 2006 | $-50.07M | -485.02% |
| 2005 | $13.00M | 15.50% |
| 2004 | $11.26M | -23.83% |
| 2003 | $14.78M | 20.06% |
| 2002 | $12.31M | 20.70% |
| 2001 | $10.20M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
